title: Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
abstract: Endocannabinoid (eCB) signaling has been identified as a modulator of adaptation to stress, and is integral to basal and stress-induced glucocorticoid regulation. Furthermore, interactions between eCBs and glucocorticoids have been shown to be necessary for the regulation of emotional memories, suggesting that eCB function may relate to the development of post-traumatic stress disorder (PTSD). To examine this, plasma eCBs were measured in a sample (n=46) drawn from a population-based cohort selected for physical proximity to the World Trade Center (WTC) at the time of the 9/11 attacks. Participants received a structured diagnostic interview and were grouped according to whether they met diagnostic criteria for PTSD (no PTSD, n=22; lifetime diagnosis of PTSD=24). eCB content (2-arachidonoylglycerol (2-AG) and anandamide (AEA)) and cortisol were measured from 8 a.m. plasma samples. Circulating 2-AG content was significantly reduced among individuals meeting diagnostic criteria for PTSD. The effect of reduced 2-AG content in PTSD remained significant after controlling for the stress of exposure to the WTC collapse, gender, depression and alcohol abuse. There were no significant group differences for AEA or cortisol levels; however, across the whole sample AEA levels positively correlated with circulating cortisol, and AEA levels exhibited a negative relationship with the degree of intrusive symptoms within the PTSD sample. This report shows that PTSD is associated with a reduction in circulating levels of the eCB 2-AG. Given the role of 2-AG in the regulation of the stress response, these data support the hypothesis that deficient eCB signaling may be a component of the glucocorticoid dysregulation associated with PTSD. The negative association between AEA levels and intrusive symptoms is consistent with animal data indicating that reductions in AEA promote retention of aversive emotional memories. Future work will aim to replicate these findings and extend their relevance to clinical pathophysiology, as well as to neuroendocrine and molecular markers of PTSD.
authors.affiliation: The Hotchkiss Brain Institute, Department of Cell Biology & Anatomy and Psychiatry, University of Calgary, Calgary, AB, Canada; Laboratory of Neuroendocrinology, The Rockefeller University, New York, NY, USA. Electronic address: mnhill@ucalgary.ca.
authors.forename: Matthew N
authors.initials: MN
authors.lastname: Hill
authors.forename: Linda M
authors.initials: LM
authors.lastname: Bierer
authors.forename: Iouri
authors.initials: I
authors.lastname: Makotkine
authors.forename: Julia A
authors.initials: JA
authors.lastname: Golier
authors.forename: Sandro
authors.initials: S
authors.lastname: Galea
authors.forename: Bruce S
authors.initials: BS
authors.lastname: McEwen
authors.forename: Cecilia J
authors.initials: CJ
authors.lastname: Hillard
authors.forename: Rachel
authors.initials: R
authors.lastname: Yehuda
mesh_terms: D000368:Aged; D000437:Alcoholism / Q000097:blood / Q000523:psychology; D000577:Amides; D001095:Arachidonic Acids / Q000097:blood; D063388:Endocannabinoids / Q000097:blood*; D004983:Ethanolamines / Q000097:blood; D005006:Ethnicity; D005260:Female; D005989:Glycerides / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D009829:Oleic Acids / Q000097:blood; D010169:Palmitic Acids / Q000097:blood; D053284:Polyunsaturated Alkamides / Q000097:blood; D011569:Psychiatric Status Rating Scales; D012727:Sex Characteristics; D013313:Stress Disorders, Post-Traumatic / Q000097:blood* / Q000523:psychology*; D023481:Terrorism
chemical_list: D000577:Amides; D001095:Arachidonic Acids; D063388:Endocannabinoids; D004983:Ethanolamines; D005989:Glycerides; D009829:Oleic Acids; D010169:Palmitic Acids; D053284:Polyunsaturated Alkamides; C488250:oleoylethanolamide; C005958:palmidrol; C094503:glyceryl 2-arachidonate; C078814:anandamide; D006854:Hydrocortisone
keywords: 2-Arachidonoylglycerol; Anandamide; Anxiety; Cortisol; Endocannabinoid; HPA axis; N-arachidonylethanolamine; PTSD; Stress; Trauma
references.citation: Eur J Neurosci. 2005 Feb;21(4):1057-69
references.pmid: 15787710
references.citation: Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4786-91
references.pmid: 23487769
references.citation: J Neurosci. 2008 Jan 23;28(4):893-903
references.pmid: 18216197
references.citation: J Neurosci. 2010 Apr 7;30(14):4990-8
references.pmid: 20371819
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Jun 30;34(5):791-7
references.pmid: 19903506
references.citation: Nicotine Tob Res. 2007 Nov;9(11):1071-84
references.pmid: 17978982
references.citation: Endocrinology. 2010 Oct;151(10):4811-9
references.pmid: 20702575
references.citation: Neuropsychopharmacology. 2012 Jan;37(2):350-63
references.pmid: 21976046
references.citation: Proc Natl Acad Sci U S A. 2010 May 18;107(20):9406-11
references.pmid: 20439721
references.citation: Brain Res. 2009 Oct 13;1293:13-23
references.pmid: 19332037
references.citation: Biol Psychiatry. 2009 Oct 1;66(7):705-7
references.pmid: 19576571
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3504-9
references.pmid: 22331883
references.citation: Mol Psychiatry. 2013 Sep;18(9):1034-40
references.pmid: 23670490
references.citation: Mol Psychiatry. 2013 Jul;18(7):813-23
references.pmid: 22688188
references.citation: Neuropsychopharmacology. 2009 Dec;34(13):2733-45
references.pmid: 19710634
references.citation: Biol Psychiatry. 2006 Apr 1;59(7):660-3
references.pmid: 16325152
references.citation: Stress. 2011 Jul;14(4):384-97
references.pmid: 21663537
references.citation: J Neurosci. 2003 Jun 15;23(12):4850-7
references.pmid: 12832507
references.citation: Dis Markers. 2011;30(2-3):101-10
references.pmid: 21508514
references.citation: PLoS One. 2013 May 07;8(5):e62741
references.pmid: 23667516
references.citation: CNS Neurol Disord Drug Targets. 2009 Dec;8(6):451-8
references.pmid: 19839936
references.citation: Rev Neurosci. 2012;23(5-6):681-90
references.pmid: 23006898
references.citation: Depress Anxiety. 2013 Feb;30(2):93-6
references.pmid: 23225490
references.citation: Endocrinology. 2004 Dec;145(12):5431-8
references.pmid: 15331569
references.citation: Biol Psychiatry. 2009 Jul 1;66(1):9-16
references.pmid: 19103437
references.citation: Neuroimmunomodulation. 2001;9(4):209-17
references.pmid: 11847483
references.citation: Neuroscience. 2012 Mar 1;204:207-29
references.pmid: 22123166
references.citation: J Am Osteopath Assoc. 2005 Jun;105(6):283-91
references.pmid: 16118355
references.citation: Neuropsychopharmacology. 2005 Mar;30(3):516-24
references.pmid: 15637635
references.citation: Exp Neurol. 2010 Jul;224(1):48-55
references.pmid: 20353771
references.citation: Psychoneuroendocrinology. 2010 Oct;35(9):1333-8
references.pmid: 20399021
references.citation: Psychopharmacology (Berl). 2009 Jul;205(1):63-72
references.pmid: 19343330
references.citation: Br J Pharmacol. 1996 Aug;118(8):2023-8
references.pmid: 8864538
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4888-93
references.pmid: 19255436
references.citation: PLoS One. 2010 May 21;5(5):e10752
references.pmid: 20505775
references.citation: J Lipid Res. 2005 Feb;46(2):342-9
references.pmid: 15576840
references.citation: Biol Psychiatry. 2009 Oct 1;66(7):708-11
references.pmid: 19393990
references.citation: Ann N Y Acad Sci. 2009 Oct;1179:56-69
references.pmid: 19906232
references.citation: Biol Psychiatry. 2000 May 15;47(10):902-9
references.pmid: 10807963
references.citation: Neuroscience. 2012 Mar 1;204:5-16
references.pmid: 22214537
references.citation: Pharmacopsychiatry. 2008 Mar;41(2):48-53
references.pmid: 18311684
references.citation: Neuropharmacology. 2005 Oct;49(5):646-52
references.pmid: 15949823
references.citation: Brain Behav Immun. 2013 May;30:125-32
references.pmid: 23379997
references.citation: Nature. 2002 Aug 1;418(6897):530-4
references.pmid: 12152079
references.citation: Biol Psychiatry. 2000 Nov 1;48(9):902-9
references.pmid: 11074228
references.citation: Psychoneuroendocrinology. 2009 Sep;34(8):1257-62
references.pmid: 19394765
references.citation: Chem Rev. 2008 May;108(5):1687-707
references.pmid: 18429637
references.citation: Neurobiol Dis. 2010 Aug;39(2):148-55
references.pmid: 20381618
references.citation: J Neurosci. 2011 Jul 20;31(29):10506-15
references.pmid: 21775596
references.citation: Biol Psychiatry. 1997 Sep 1;42(5):345-8
references.pmid: 9276074
references.citation: Biol Psychiatry. 2000 Mar 15;47(6):526-39
references.pmid: 10715359
references.citation: J Trauma Stress. 1995 Jan;8(1):75-90
references.pmid: 7712061
references.citation: Prog Brain Res. 2010;182:149-60
references.pmid: 20541663
references.citation: Neuropsychopharmacology. 2012 Oct;37(11):2416-27
references.pmid: 22763622